The Dementia Diagnosis Gap Is Wider Than We Think
Alzheimer’s costs American families upwards of $360 billion per year, and with our growing aging population, the disease needs to be more of a public health priority.
Acuity-driven Care — Leveraging Multi-level Monitoring for Complex Needs
It's time that the healthcare industry transitioned from isolated point solutions to an integrated care model that incorporates remote monitoring and virtual care management.
What Do Early Stage Life Science Companies Need to Grow?
Scheduled for May 8 at 1 pm ET, the conversation will include Morgan Cheatham, head of healthcare and life sciences at Breyer Capital, Gurdane Bhutani, founder and managing partner of MBX Capital, and will be moderated by Mercury Head of Healthcare and Life Sciences Ben Kromnick.
Are Therapy-Bots Really Our Best Chance At Solving Population Mental Health?
Like bandaids, AI chatbots can comfort us in times of desperation. But healing a wound takes more than a comforting bandaid.
The Policy Trends the Business Group on Health Is Watching
The Business Group on Health is paying attention to Medicaid cuts, tariffs, threats to ERISA and more.